VaxCare

• Led a proprietary growth investment in 2020 to support national expansion and platform development
• Helped recruit key leaders, including a new COO and two independent board directors: Dave King (former CEO of LabCorp) and Ken Burdick (former CEO of WellCare Health Plans)
• Partnered closely with management to help scale go-to-market efforts and deepen adoption across health systems and physician practices, with the company signing contracts with eight of the leading healthcare systems in the U.S.
• Supported the evolution of the platform beyond vaccines to other physician-administered drugs, enabling entry into new clinical areas
• Assisted the team in strengthening operational infrastructure, data capabilities and reporting systems to support multi-state growth and enterprise-level visibility
• Worked alongside the founder and executive team to help refine strategy and position VaxCare as the largest primary care vaccinator networks in the U.S.⁽¹⁾

As VaxCare looks ahead, the company remains focused on expanding its network by continuing to create better paths to care for patients, providers and practices. With its integrated platform, expanding clinical use cases and a growing network of provider and health system partners, we believe VaxCare is well-positioned to continue delivering on its mission in a healthcare system that demands simplicity, efficiency and better outcomes.

‍

‍

‍

‍

‍

^{Certain statements about Summit Partners made by Casey DeLoach herein are intended to illustrate Summit Partners’ business relationship with VaxCare, Inc. (“VaxCare”) and Mr. DeLoach, including with respect to Summit Partners’ role as a business partner, rather than reflect Summit Partners’ capabilities or expertise with respect to investment advisory services.  Mr. DeLoach was not compensated in connection with his participation or statements; however, he has received and continues to receive compensation in connection with his employment at VaxCare. Mr. DeLoach is not an investor in a Summit fund but may have conflicts arising from his current role with VaxCare due to VaxCare’s relationship with Summit.}  

^{Further, the information presented herein represents the views and opinions of Summit Partners as well as present executives of VaxCare, which is inherently uncertain and based on a number of assumptions. Such information should not be construed or relied upon as an indication of future performance or other future outcomes.}

^{(1) As of November 1, 2024, unless otherwise noted. The information was provided by the Company and is believed to be reliable and current, but accuracy cannot be guaranteed. Past operating performance is not a guarantee of or necessarily indicative of future results. There can be no assurance that any trend illustrated herein will continue.}‍